kabutan

Japan Tissue Engineering, Ordinary Profit Forecast for the Fiscal Year Revised Downward to a loss of 540 Million Yen

Fri Jan 30, 2026 3:00 pm JST Earnings

7774 Japan Tissue Engineering Co., Ltd. 【J-GAAP】

Earnings Report

Japan Tissue Engineering Co., Ltd. <7774> [TSE Growth] announced its financial results in the afternoon session on January 30th (15:00). The ordinary loss (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2026 (April to December) expanded to a loss of 552 million yen (compared to a loss of 330 million yen in the same period last year).

In addition, the full-year forecast for ordinary profit/loss has been revised downward from the previous range of 110 million to 210 million yen to a new loss of 540 million yen.

Based on the cumulative third-quarter performance announced by the company and the full-year plan, our calculation indicates that the ordinary profit for the January to March period (4Q) is expected to significant drop 87.5% from the same period last year to 12 million yen.

In the most recent three-month period, from October to December (3Q), the ordinary loss expanded to a loss of 183 million yen (compared to a loss of 124 million yen in the same period last year). The operating profit/loss margin drastically worsened from -22.8% in the same period last year to -36.6%.

Note: If the earnings forecast is disclosed as a range, the article is based on the midpoint of that range.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 1,785 -51 -50 -53 -1.3 ー Jan 30, 2024 J-GAAP
Apr - Dec, 2024 1,706 -331 -330 -350 -8.6 ー Jan 31, 2025 J-GAAP
Apr - Dec, 2025 1,509 -563 -552 -556 -13.7 ー Jan 30, 2026 J-GAAP
YoY -11.5% -70.1% -67.3% -58.9% -58.9%

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2025 Prev 2,002 526 529 516 12.7 0 Oct 31, 2025 J-GAAP
Oct - Mar, 2025 New 1,212 -174 -171 -169 -4.2 0 Jan 30, 2026 J-GAAP
Revision Rate -39.5% － － － －

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 3,000 150 160 145 3.6 0 Apr 30, 2025 J-GAAP
Mar, 2026 New 2,210 -550 -540 -540 -13.3 0 Jan 30, 2026 J-GAAP
Revision Rate -26.3% － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 1,294 -31 -28 -30 -0.7 0 Apr 30, 2025 J-GAAP
Oct - Mar, 2025 Guidance 1,212 -174 -171 -169 -4.2 0 Jan 30, 2026 J-GAAP
YoY -6.3% -461.3% -510.7% -463.3% -462.2%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 2,514 144 147 143 3.5 0 Apr 30, 2024 J-GAAP
Mar, 2025 2,455 -238 -234 -255 -6.3 0 Apr 30, 2025 J-GAAP
Mar, 2026 Guidance 2,210 -550 -540 -540 -13.3 0 Jan 30, 2026 J-GAAP
YoY -10.0% -131.1% -130.8% -111.8% -111.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 545 -124 -124 -125 -3.1 -22.8 Jan 31, 2025 J-GAAP
Jan - Mar, 2025 749 93 96 95 2.3 12.4 Apr 30, 2025 J-GAAP
Apr - Jun, 2025 426 -244 -241 -242 -6.0 -57.3 Jul 30, 2025 J-GAAP
Jul - Sep, 2025 572 -132 -128 -129 -3.2 -23.1 Oct 31, 2025 J-GAAP
Oct - Dec, 2025 511 -187 -183 -185 -4.6 -36.6 Jan 30, 2026 J-GAAP
YoY -6.2% -50.8% -47.6% -48.0% -48.1%

Related Articles